These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72. Recent advances in the pharmacotherapeutic management of diabetic kidney disease. Block TJ; Batu D; Cooper ME Expert Opin Pharmacother; 2022 May; 23(7):791-803. PubMed ID: 35522659 [TBL] [Abstract][Full Text] [Related]
73. The protective effects of SGLT-2 inhibitors, GLP-1 receptor agonists, and RAAS blockers against renal injury in patients with type 2 diabetes. Kuang Z; Hou N; Kan C; Han F; Qiu H; Sun X Int Urol Nephrol; 2023 Mar; 55(3):617-629. PubMed ID: 36036316 [TBL] [Abstract][Full Text] [Related]
74. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies. Warren AM; Knudsen ST; Cooper ME Expert Opin Ther Targets; 2019 Jul; 23(7):579-591. PubMed ID: 31154867 [No Abstract] [Full Text] [Related]